Jennifer Schneider Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Jennifer Schneider is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 1,718 shares of VRTX, which is worth approximately $822,870. The most recent transaction as insider was on May 01, 2025, when has been sold 796 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.72K

86.33% 3M change

86.33% 12M change

Total Value Held $822,870

Jennifer Schneider Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 01 2025	BUY Grant, award, or other acquisition	-	796 Added 31.66%	1,718 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	922 Added 50.0%	922 Common Stock

Also insider at

LVGO

Livongo Health, Inc.

President